2020-12-16 • Updated
Well, as expected, Pfizer’s stock price fell. Why? Because the emotional wave that pushed it up is exhausted. It went to $43 on the vaccine news. But what was the news? That the vaccine is ready, that has more than 90% of efficacy, that it is to be distributed, etc. And that’s good enough. But the virus is still there, right? In the US and in Europe, the rates are as high as ever in certain regions, restrictions are double-enforced in some cities. Therefore, the joy of knowing that the vaccine is coming couldn’t have had but a temporary effect. In the meantime, the fundamental layout doesn’t offer any specific reason why Pfizer’s stock would leap and stay too excited. Is that a bad investment option then?
No, not at all. By releasing the vaccine, Pfizer confirmed that they are a solid pharma company – as they’ve been until now - able to deliver when needed. Probably, they needed this opportunity to shine again and spur its market capitalization back to the upside, and it happened exactly this way. In a downtrend since the second part of 2018, Pfizer’s stock recovered well from the virus hit and reached $40 – a level it last visited a year ago. Now, even with a local cooling off, this stock seems to be well set for the upside. Therefore, the suggestion to trade it is the following: go mid-term, give a while to cool off and reach a local bottom, the buy when you see a bullish reversal from the current downturn. If you reserve a month or so to hold it, it may well reach $42 again – that’s the recommended Take Profit for a position trading strategy. Don’t forget to put the Stop Loss: $36 appears to be appropriate to guard the downside.
Don't know how to trade stocks? Here are some simple steps.
During the Asian session on Wednesday, the USD/CAD pair rebounded after two days of losses, reaching around 1.3590. This uptick is fueled by a stronger US dollar and lower crude oil prices, which put pressure on the Canadian dollar. The decline in Western Texas Intermediate (WTI) oil prices to approximately $80.70 is attributed to...
The Australian Dollar (AUD) rebounds on Monday, despite a slight dip in the US Dollar (USD) and higher US Treasury yields. Investors are eyeing Australian monthly Consumer Price Index (CPI) data for February and US Gross Domestic Product (GDP) for Q4 2023. The AUD gains momentum as the ASX 200 Index rises, especially in mining and energy sectors. Additionally, the Aussie...
Gold prices rose on Monday as the US Dollar weakened amidst speculation about potential Federal Reserve rate cuts starting in June. This weakened Dollar was partly due to improved risk sentiment pushing US Treasury yields lower. Despite facing challenges from declining yields, gold prices recovered to nearly $2,170 per troy ounce, driven by the Dollar's weakness. Federal Reserve Chair...
Jerome H. Powell, the Federal Reserve chair, stated that the central bank can afford to be patient in deciding when to cut interest rates, citing easing inflation and stable economic growth. Powell emphasized the Fed's independence from political influences, particularly relevant as the election season nears. The Fed had raised interest rates to 5.3 ...
Hello again my friends, it’s time for another episode of “What to Trade,” this time, for the month of April. As usual, I present to you some of my most anticipated trade ideas for the month of April, according to my technical analysis style. I therefore encourage you to do your due diligence, as always, and manage your risks appropriately.
Bearish scenario: Sell below 1.0820 / 1.0841... Bullish scenario: Buy above 1.0827...
FBS maintains a record of your data to run this website. By pressing the “Accept” button, you agree to our Privacy policy.
Your request is accepted.
A manager will call you shortly.
Next callback request for this phone number
will be available in
If you have an urgent issue please contact us via
Live chat
Internal error. Please try again later
Don’t waste your time – keep track of how NFP affects the US dollar and profit!
|
